RESUMEN
BACKGROUND: The present survey aims to describe the intensive cardiac care unit organization and admission policies in Europe. METHODS: A total of 228 hospitals (61% academic) from 27 countries participated in this survey. In addition to the organizational aspects of the intensive cardiac care units, including classification of the intensive cardiac care unit levels, data on the admission diagnoses were gathered from consecutive patients who were admitted during a two-day period. Admission policies were evaluated by comparing illness severity with the intensive cardiac care unit level. Gross national income was used to differentiate high-income countries (n=13) from middle-income countries (n=14). RESULTS: A total of 98% of the hospitals had an intensive cardiac care unit: 70% had a level 1 intensive cardiac care unit, 76% had a level 2 intensive cardiac care unit, 51% had a level 3 intensive cardiac care unit, and 60% of the hospitals had more than one intensive cardiac care unit level. High-income countries tended to have more level 3 intensive cardiac care units than middle-income countries (55% versus 41%, p=0.07). A total of 5159 admissions were scored on illness severity: 63% were low severity, 24% were intermediate severity, and 12% were high severity. Patients with low illness severity were predominantly admitted to level 1 intensive cardiac care units, whereas patients with high illness severity were predominantly admitted to level 2 and 3 intensive cardiac care units. A policy mismatch was observed in 12% of the patients; some patients with high illness severity were admitted to level 1 intensive cardiac care units, which occurred more often in middle-income countries, whereas some patients with low illness severity were admitted to level 3 intensive cardiac care units, which occurred more frequently in high-income countries. CONCLUSION: More than one-third of the admitted patients were considered intermediate or high risk. Although patients with higher illness severity were mostly admitted to high-level intensive cardiac care units, an admission policy mismatch was observed in 12% of the patients; this mismatch was partly related to insufficient logistic intensive cardiac care unit capacity.
Asunto(s)
Cardiopatías/terapia , Unidades de Cuidados Intensivos/organización & administración , Admisión del Paciente/estadística & datos numéricos , Europa (Continente)/epidemiología , Cardiopatías/epidemiología , Humanos , Morbilidad/tendencias , Factores de Riesgo , Encuestas y CuestionariosRESUMEN
A case of choriocarcinoma in 33-year old woman after ectopic pregnancy has been reported. CT-scan established an invasion of the vagina, posterior wall of the bladder and rectum. The patient's leading symptoms were: severe genital bleeding,haematuria, acute postbleeding anaemia, haemorrhagical shock. After treatment with Metothrexate and symptomatic therapy the patient achieved complete clinical remission and she is free of disease 18 months after the onset of the therapy.
Asunto(s)
Antimetabolitos Antineoplásicos/uso terapéutico , Coriocarcinoma/tratamiento farmacológico , Metotrexato/uso terapéutico , Embarazo Ectópico , Neoplasias Uterinas/tratamiento farmacológico , Adulto , Antimetabolitos Antineoplásicos/administración & dosificación , Coriocarcinoma/etiología , Coriocarcinoma/patología , Supervivencia sin Enfermedad , Femenino , Humanos , Metotrexato/administración & dosificación , Invasividad Neoplásica , Embarazo , Embarazo Ectópico/tratamiento farmacológico , Resultado del Tratamiento , Neoplasias Uterinas/etiología , Neoplasias Uterinas/patologíaRESUMEN
Transthoracic electrical defibrillation is administered by high voltages and currents applied through large size electrodes. Therefore, the defibrillator load impedance becomes an essential factorfor the efficacy of the procedure. Attempts at prediction of transthoracic impedance by pre-shock measurement with low-amplitude high-frequency current have yielded apparently promising results. A reassessment was undertaken of the comparison between transthoracic impedance measured over a wide frequency range (bioimpedance spectroscopy) and measured during the shock. An estimation of the possibilities for pre-shock 'prediction ' of the impedance was performed, to allow adequate selection of the defibrillation energy or current with the intention of increasing the possibility for positive results with the first shock. Data were obtained from experimental fibrillation/defibrillation cycles on dogs andfrom cardioversion of atrial fibrillation or flutter in patients. The final results suggest that high-frequency low-amplitude impedance measurements cannot predict the corresponding value during the shock with very high accuracy, as differences up to 15-17% were found using biphasic pulses in patients. However, the method can be used for approximate assessments.
Asunto(s)
Cardioversión Eléctrica , Tórax/fisiología , Adulto , Anciano , Animales , Fibrilación Atrial/fisiopatología , Fibrilación Atrial/terapia , Aleteo Atrial/fisiopatología , Aleteo Atrial/terapia , Perros , Impedancia Eléctrica , Humanos , Persona de Mediana EdadRESUMEN
Various electrical pulses have been used for defibrillation. The monophasic damped sinusoid waveform, initiated in 60 s, was adopted in virtually all defibrillators. Biphasic pulses were introduced recently, achieving success with less energy. A biphasic exponential waveform was modelled with 4 ms duration per phase with a balanced 3:1 ratio of the first to second phase peak voltages and implemented in a defibrillator. A version obtained by chopping the pulses with a 5 kHz frequency was also used. It was hypothesized that the modelled transmembrane voltage decay time is a parameter that could be associated with successful defibrillation. The results of cardioversion for two groups of patients with the 'classic' monophasic waveform and with the biphasic pulses were compared. The mean efficient energy with the damped sinusoid was 205 +/- 85 J, versus 88 +/- 43 J with the biphasic pulses, yielding a ratio of 2.32 (1.92 to 3.2 for fibrillation and flutter, respectively). An acceptable agreement between model data and clinical results was found. The transmembrane voltage decay time ratios for monophasic versus biphasic pulses was in the approximate range of 2.5 to 3.5.
Asunto(s)
Fibrilación Atrial/terapia , Aleteo Atrial/terapia , Cardioversión Eléctrica , Cardioversión Eléctrica/instrumentación , Cardioversión Eléctrica/métodos , Electrocardiografía , Femenino , Humanos , MasculinoRESUMEN
The transthoracic electrical impedance is an important defibrillation parameter, affecting the defibrillating current amplitude and energy, and therefore the defibrillation efficiency. A close relationship between transthoracic impedance and defibrillation success rate was observed. Pre-shock measurements (using low amplitude high frequency current) of the impedance were considered a solution for selection of adequate shock voltages or for current-based defibrillation dosage. A recent approach, called 'impedance-compensating defibrillation' was implemented, where the pulse duration was controlled with respect to the impedance measured during the initial phase of the shock. These considerations raised our interest in reassessment of the transthoracic impedance characteristics and the corresponding measurement methods. The purpose of this work is to study the variations of the transthoracic impedance by a continuous measurement technique during the defibrillation shock and comparing the data with results obtained by modelling. Voltage and current impulse waveforms were acquired during cardioversion of patients with atrial fibrillation or flutter. The same type of defibrillation pulse was taken from dogs after induction of fibrillation. The electrodes were located in the anterior position, for both the patients and animals.